• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多基因模式在罕见类型垂体功能减退症中的发现:汉族垂体柄中断综合征的全外显子组测序研究。

Multi-genic pattern found in rare type of hypopituitarism: a whole-exome sequencing study of Han Chinese with pituitary stalk interruption syndrome.

机构信息

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

Department of Endocrinology, Hainan Branch of Chinese PLA General Hospital, Sanya, Hainan, China.

出版信息

J Cell Mol Med. 2017 Dec;21(12):3626-3632. doi: 10.1111/jcmm.13272. Epub 2017 Jul 14.

DOI:10.1111/jcmm.13272
PMID:28707430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5706574/
Abstract

Pituitary stalk interruption syndrome (PSIS) is a rare type of hypopituitarism manifesting various degrees of pituitary hormone deficiency. Although mutations have been identified in some familial cases, the underpinning mechanisms of sporadic patients with PSIS who are in a vast majority remain elusive, necessitating a comprehensive study using systemic approaches. We postulate that other genetic mechanisms may be responsible for the sporadic PSIS. To test this hypothesis, we conducted a study in 24 patients with PSIS of Han Chinese with no family history using whole-exome sequencing (WES) and bioinformatic analysis. We identified a group of heterozygous mutations in 92% (22 of 24) of the patients, and these genes are mostly associated with Notch, Shh, Wnt signalling pathways. Importantly, 83% (20 of 24) of the patients had more than one mutation in those pathways suggesting synergy of compound mutations underpin the pathogenesis of sporadic PSIS.

摘要

垂体柄中断综合征(PSIS)是一种罕见的垂体功能减退症,表现为不同程度的垂体激素缺乏。虽然在一些家族性病例中已经发现了突变,但绝大多数散发性 PSIS 患者的潜在机制仍难以捉摸,需要使用系统方法进行全面研究。我们假设其他遗传机制可能与散发性 PSIS 有关。为了验证这一假说,我们使用全外显子组测序(WES)和生物信息学分析对 24 名无家族史的汉族 PSIS 患者进行了研究。我们在 92%(22/24)的患者中发现了一组杂合突变,这些基因主要与 Notch、Shh、Wnt 信号通路有关。重要的是,83%(20/24)的患者在这些通路中存在不止一种突变,这表明复合突变的协同作用是散发性 PSIS 发病机制的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/95d4c133e3fe/JCMM-21-3626-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/9d4ca8564ada/JCMM-21-3626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/a98478fd6978/JCMM-21-3626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/87b880ea4297/JCMM-21-3626-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/95d4c133e3fe/JCMM-21-3626-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/9d4ca8564ada/JCMM-21-3626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/a98478fd6978/JCMM-21-3626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/87b880ea4297/JCMM-21-3626-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d0/5706574/95d4c133e3fe/JCMM-21-3626-g004.jpg

相似文献

1
Multi-genic pattern found in rare type of hypopituitarism: a whole-exome sequencing study of Han Chinese with pituitary stalk interruption syndrome.多基因模式在罕见类型垂体功能减退症中的发现:汉族垂体柄中断综合征的全外显子组测序研究。
J Cell Mol Med. 2017 Dec;21(12):3626-3632. doi: 10.1111/jcmm.13272. Epub 2017 Jul 14.
2
Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome.全外显子组测序在一个患有垂体柄中断综合征的家族中鉴定出纯合的GPR161突变。
J Clin Endocrinol Metab. 2015 Jan;100(1):E140-7. doi: 10.1210/jc.2014-1984.
3
Pituitary Stalk Interruption Syndrome: From Clinical Findings to Pathogenesis.垂体柄阻断综合征:从临床表现到发病机制
J Neuroendocrinol. 2017 Jan;29(1). doi: 10.1111/jne.12451.
4
Digenic Inheritance of PROKR2 and WDR11 Mutations in Pituitary Stalk Interruption Syndrome.垂体柄中断综合征中PROKR2和WDR11突变的双基因遗传
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2501-2507. doi: 10.1210/jc.2017-00332.
5
Pituitary stalk interruption syndrome.垂体柄阻断综合征。
Handb Clin Neurol. 2021;181:9-27. doi: 10.1016/B978-0-12-820683-6.00002-6.
6
Re-analysis of gene mutations found in pituitary stalk interruption syndrome and a new hypothesis on the etiology.垂体柄阻断综合征中基因突变的重新分析及病因新假说
Front Endocrinol (Lausanne). 2024 Feb 23;15:1338781. doi: 10.3389/fendo.2024.1338781. eCollection 2024.
7
Mutations in the Human ROBO1 Gene in Pituitary Stalk Interruption Syndrome.人类 ROBO1 基因中的突变与垂体柄中断综合征有关。
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2401-2406. doi: 10.1210/jc.2016-1095.
8
PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.多个伴有垂体柄中断的垂体功能减退症中的 PROKR2 变异体。
J Clin Endocrinol Metab. 2012 Jun;97(6):E1068-73. doi: 10.1210/jc.2011-3056. Epub 2012 Mar 30.
9
Pituitary stalk interruption syndrome due to novel mutation presenting as combined pituitary hormone deficiency and central diabetes insipidus.因新型突变导致的垂体柄中断综合征,表现为联合垂体激素缺乏症和中枢性尿崩症。
J Pediatr Endocrinol Metab. 2024 Mar 7;37(5):477-481. doi: 10.1515/jpem-2023-0541. Print 2024 May 27.
10
Exome sequencing in 16 patients with pituitary stalk interruption syndrome: A monocentric study.16 例垂体柄中断综合征患者的外显子组测序:一项单中心研究。
PLoS One. 2023 Dec 14;18(12):e0292664. doi: 10.1371/journal.pone.0292664. eCollection 2023.

引用本文的文献

1
Pituitary Stalk Interruption Syndrome: A Case Series.垂体柄阻断综合征:病例系列
Cureus. 2025 May 19;17(5):e84437. doi: 10.7759/cureus.84437. eCollection 2025 May.
2
Pulsatile gonadotropin-releasing hormone therapy induces spermatogenesis in pituitary stalk interruption syndrome: A case report and review of the literature.脉冲式促性腺激素释放激素疗法诱导垂体柄中断综合征患者精子发生:一例报告并文献复习
World J Clin Cases. 2024 Jul 16;12(20):4348-4356. doi: 10.12998/wjcc.v12.i20.4348.
3
Re-analysis of gene mutations found in pituitary stalk interruption syndrome and a new hypothesis on the etiology.

本文引用的文献

1
Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.范可尼贫血:中枢神经系统畸形与基因互补组的关联
Pediatr Radiol. 2017 Jun;47(7):868-876. doi: 10.1007/s00247-017-3817-x. Epub 2017 Mar 10.
2
Pituitary Stalk Interruption Syndrome: From Clinical Findings to Pathogenesis.垂体柄阻断综合征:从临床表现到发病机制
J Neuroendocrinol. 2017 Jan;29(1). doi: 10.1111/jne.12451.
3
Hypopituitarism.垂体功能减退症
垂体柄阻断综合征中基因突变的重新分析及病因新假说
Front Endocrinol (Lausanne). 2024 Feb 23;15:1338781. doi: 10.3389/fendo.2024.1338781. eCollection 2024.
4
Exome sequencing in 16 patients with pituitary stalk interruption syndrome: A monocentric study.16 例垂体柄中断综合征患者的外显子组测序:一项单中心研究。
PLoS One. 2023 Dec 14;18(12):e0292664. doi: 10.1371/journal.pone.0292664. eCollection 2023.
5
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events.垂体柄阻断综合征:围生期事件的表型、预测因素和病理生理学。
Pituitary. 2022 Aug;25(4):645-652. doi: 10.1007/s11102-022-01243-x. Epub 2022 Jun 24.
6
Advances in differential diagnosis and management of growth hormone deficiency in children.儿童生长激素缺乏症的鉴别诊断与管理进展
Nat Rev Endocrinol. 2021 Oct;17(10):608-624. doi: 10.1038/s41574-021-00539-5. Epub 2021 Aug 20.
7
CDON gene contributes to pituitary stalk interruption syndrome associated with unilateral facial and abducens nerve palsy.CDON 基因与单侧面部和展神经麻痹相关的垂体柄中断综合征有关。
J Appl Genet. 2021 Dec;62(4):621-629. doi: 10.1007/s13353-021-00649-w. Epub 2021 Jul 8.
8
Diversity of Pathological Conditions Affecting Pituitary Stalk.影响垂体柄的病理状况的多样性
J Clin Med. 2021 Apr 14;10(8):1692. doi: 10.3390/jcm10081692.
9
Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms.垂体柄阻断综合征与肝脏改变:从临床特征到发病机制。
World J Gastroenterol. 2020 Nov 28;26(44):6909-6922. doi: 10.3748/wjg.v26.i44.6909.
10
Identification of novel candidate pathogenic genes in pituitary stalk interruption syndrome by whole-exome sequencing.通过全外显子组测序鉴定垂体柄中断综合征的新候选致病基因。
J Cell Mol Med. 2020 Oct;24(20):11703-11717. doi: 10.1111/jcmm.15781. Epub 2020 Aug 31.
Lancet. 2016 Nov 12;388(10058):2403-2415. doi: 10.1016/S0140-6736(16)30053-8. Epub 2016 Mar 31.
4
A Nonsense Mutation in the Hedgehog Receptor CDON Associated With Pituitary Stalk Interruption Syndrome.与垂体柄中断综合征相关的刺猬受体CDON中的无义突变。
J Clin Endocrinol Metab. 2016 Jan;101(1):12-5. doi: 10.1210/jc.2015-2995. Epub 2015 Nov 3.
5
Frequency of genetic defects in combined pituitary hormone deficiency: a systematic review and analysis of a multicentre Italian cohort.联合垂体激素缺乏症中基因缺陷的发生率:一项对意大利多中心队列的系统评价与分析
Clin Endocrinol (Oxf). 2015 Dec;83(6):849-60. doi: 10.1111/cen.12849. Epub 2015 Aug 6.
6
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.NKD2是Wnt信号通路的负调控因子,可抑制骨肉瘤的肿瘤生长和转移。
Oncogene. 2015 Sep 24;34(39):5069-79. doi: 10.1038/onc.2014.429. Epub 2015 Jan 12.
7
Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.范可尼贫血中的内分泌紊乱:筛查与治疗建议
J Clin Endocrinol Metab. 2015 Mar;100(3):803-11. doi: 10.1210/jc.2014-4357. Epub 2015 Jan 9.
8
Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome.全外显子组测序在一个患有垂体柄中断综合征的家族中鉴定出纯合的GPR161突变。
J Clin Endocrinol Metab. 2015 Jan;100(1):E140-7. doi: 10.1210/jc.2014-1984.
9
Ncor2 is required for hematopoietic stem cell emergence by inhibiting Fos signaling in zebrafish.Ncor2 通过抑制斑马鱼中的 Fos 信号传导来促进造血干细胞的出现。
Blood. 2014 Sep 4;124(10):1578-85. doi: 10.1182/blood-2013-11-541391. Epub 2014 Jul 8.
10
Notch signaling in postnatal pituitary expansion: proliferation, progenitors, and cell specification.出生后垂体扩张中的Notch信号传导:增殖、祖细胞与细胞分化
Mol Endocrinol. 2014 May;28(5):731-44. doi: 10.1210/me.2013-1425. Epub 2014 Mar 27.